JP2024540097A5 - - Google Patents

Info

Publication number
JP2024540097A5
JP2024540097A5 JP2024525379A JP2024525379A JP2024540097A5 JP 2024540097 A5 JP2024540097 A5 JP 2024540097A5 JP 2024525379 A JP2024525379 A JP 2024525379A JP 2024525379 A JP2024525379 A JP 2024525379A JP 2024540097 A5 JP2024540097 A5 JP 2024540097A5
Authority
JP
Japan
Prior art keywords
molecule
nucleic acid
group
target nucleic
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525379A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540097A (ja
Filing date
Publication date
Priority claimed from GBGB2115540.3A external-priority patent/GB202115540D0/en
Application filed filed Critical
Publication of JP2024540097A publication Critical patent/JP2024540097A/ja
Publication of JP2024540097A5 publication Critical patent/JP2024540097A5/ja
Pending legal-status Critical Current

Links

JP2024525379A 2021-10-28 2022-10-28 核酸切断のための方法 Pending JP2024540097A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2115540.3 2021-10-28
GBGB2115540.3A GB202115540D0 (en) 2021-10-28 2021-10-28 Methods for nucleic acid cleavage
PCT/EP2022/080220 WO2023073181A2 (en) 2021-10-28 2022-10-28 Methods for nucleic acid cleavage

Publications (2)

Publication Number Publication Date
JP2024540097A JP2024540097A (ja) 2024-10-31
JP2024540097A5 true JP2024540097A5 (cg-RX-API-DMAC7.html) 2025-11-05

Family

ID=78828356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525379A Pending JP2024540097A (ja) 2021-10-28 2022-10-28 核酸切断のための方法

Country Status (7)

Country Link
US (1) US20240417778A1 (cg-RX-API-DMAC7.html)
EP (1) EP4423295A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024540097A (cg-RX-API-DMAC7.html)
AU (1) AU2022378590A1 (cg-RX-API-DMAC7.html)
CA (1) CA3236292A1 (cg-RX-API-DMAC7.html)
GB (1) GB202115540D0 (cg-RX-API-DMAC7.html)
WO (1) WO2023073181A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202300886D0 (en) * 2023-01-20 2023-03-08 Cambridge Entpr Ltd Compounds for nucleic acid cleavage
GB202300884D0 (en) * 2023-01-20 2023-03-08 Cambridge Entpr Ltd Compounds for nucleic acid cleavage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230272460A1 (en) * 2020-08-12 2023-08-31 Cambridge Enterprise Limited Method for Targeted Nucleic Acid Cleavage

Similar Documents

Publication Publication Date Title
JP7454760B2 (ja) ナノポア配列決定で使用するための移動制御エレメント、レポーターコード、および移動制御のためのさらなる手段
JP2021531826A5 (cg-RX-API-DMAC7.html)
US12029790B2 (en) Biomimetic nanomaterials and uses thereof
JP5346585B2 (ja) カチオン性オリゴヌクレオチド、同ヌクレオチドの自動調製法およびそれらの使用
US9962449B2 (en) MultiLigand agent for drug delivery
JP2024028453A5 (cg-RX-API-DMAC7.html)
CN106279300B (zh) Rig-i配体及其生产方法
JP2022507282A5 (cg-RX-API-DMAC7.html)
JP2021011503A5 (ja) 製剤用脂質ナノ粒子
RU2016142510A (ru) Соединения и способы для транс-мембранной доставки молекул
JPH09504515A (ja) ポリマー変性
JP2013525414A5 (cg-RX-API-DMAC7.html)
JP2013540841A5 (cg-RX-API-DMAC7.html)
KR960701888A (ko) 신규의 펩티드 핵산
RU2011150787A (ru) КОНЪЮГАТ миРНК И СПОСОБ ЕГО ПОЛУЧЕНИЯ
JP2011522070A (ja) ミセル集合体
AR052441A1 (es) Suspension no acuosa inyectable
JP2022512941A5 (cg-RX-API-DMAC7.html)
TW490306B (en) Compositions and methods for enhancing delivery of therapeutic agents to cells
JP2013510181A5 (cg-RX-API-DMAC7.html)
WO2007099660A1 (ja) 核酸内包高分子ミセル複合体
JP2025542331A (ja) 新規rna治療薬及びその使用
CA3232690A1 (en) Multi-motif dendrons and their supramolecular structures and uses thereof
CN118108613A (zh) 一种阳离子脂质化合物及制备方法和应用、mRNA递送系统
McCollum et al. Safety and biodistribution of nanoligomers targeting the SARS-CoV-2 genome for the treatment of COVID-19